Danaher to Buy Diagnostics Company Cepheid for $4 Billion

September 6, 2016 11:20 AM

20 0

Danaher to Buy Diagnostics Company Cepheid for $4 Billion

Deal marks a 54% premium over Cepheid’s closing share price Friday

The deal marks a 54% premium over Cepheid’s closing share price Friday, valuing the company at about $4 billion, including debt.

Also read: Buffett's Berkshire Hathaway will not increase its Oncor offer

Read more

To category page

Loading...